Portfolio map · Corporate investor · United States
SR One portfolio map
59 startups SR One has backed in rounds we track, since 2002, grouped by their main sector. Together they have raised $8.3B; SR One led at least one round in 2 of them. The biggest sector is Biotech, with 45 companies.
59startups backed
3sectors
$8.3Braised between them
Biotechbiggest sector
Biotech
45- TPTurning Point Therapeutics
Dren Bio
Windward BioAlumis
Morphic Therapeutic
CORXEL Pharmaceuticals
Arcellx
Odyssey Therapeutics
AirNexis Therapeutics
Spero Therapeutics
Decibel Therapeutics
HotSpot Therapeutics
MiroBio
True North Therapeutics- TTTP Therapeutics
MISSION Therapeutics
Pulmocide
Bicycle Therapeutics
FORE Biotherapeutics
Palleon Pharmaceuticals
Addition Therapeutics
Effector Therapeutics
NuPathe
Principia BioPharma
+21 more
Funding by segment
- Biotech$5.7B45
- Pharma$1.9B9
- Healthtech$682M5
Where they are based
- United States42$6.4B
- United Kingdom9$872M
- Switzerland1$365M
- Denmark1$84M
- Canada1$3.3M
- Japan1$39M
- France1$143K
United States
United Kingdom
Switzerland
Denmark
Canada
Japan
FranceFounded
18Earlier
112
613
214
515
116
217
118
419
120
321
122
223
24
25
26
12 without a founding year on record.
Total raised
- Under $1M1
- $1M to $10M1
- $10M to $50M16
- $50M to $250M30
- $250M to $1B11
- $1B and over0
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
46 of 59 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United States42
- United Kingdom9
- Switzerland1
- Denmark1
- Canada1
- Japan1
- France1
Startups by country, 7 countries in all.
Segment by segment
Biotech
45 startups · $5.7B raised
- TPTurning Point TherapeuticsTurning Point Therapeutics is a pharmaceutical company that discovers and develops precision medicines for cancer and other diseases.-$460M
- Dren BioDren Bio focuses on protein engineering technologies for depletion of cells, protein aggregates, and other disease-causing agents.United States$375M
- Windward BioWindward Bio is a clinical-stage biotechnology company with deep discovery, development, and commercialization expertise committedSwitzerland$365M
- Morphic TherapeuticMorphic Therapeutic is a biotechnology company that develops oral integrin therapies to treat serious chronic diseases.United States$328M
- CORXEL PharmaceuticalsCORXEL Pharmaceuticals is a clinical-stage biopharmaceutical company founded in 2019, previously known as JiXing Pharmaceuticals.United States$287M
- ArcellxArcellx is a clinical-stage biotechnology company focused on developing innovative immunotherapies for cancer and other incurable diseases.United States$285M
- Odyssey TherapeuticsOdyssey Therapeutics creates precision immunomodulators and oncology medicines for patients with cancer and inflammatory diseases.United States$238M
Pharma
9 startups · $1.9B raised
CRISPR THERAPEUTICSCRISPR Therapeutics is focused on the development of transformative medicines using its proprietary CRISPR/Cas9 gene-editing platform.United States$550M
Zenas BioPharmaZenas BioPharma is a biopharmaceutical company that focuses on developing immune-based therapies for patients.United States$420M- CTCrystalys TherapeuticsUnited States$335M
ORIC PharmaceuticalsORIC Pharmaceuticals is a biopharmaceutical company that develops treatments that target the causes of therapeutic resistance.United States$248M
Draig TherapeuticsDraig Therapeutics is a clinical-stage biotechnology company based in Cardiff, Wales, focused on developing innovative neuropsychiUnited Kingdom$216M
ARS PharmaceuticalsARS Pharmaceuticals is a stealth pharmaceutical company that specializes in developing anti allergy drugs.United States$100M
Renalys PharmaRenalys Pharma is a private, late-stage clinical biopharmaceutical business in Japan focused on the discovery of novel medications.Japan$39M- GTGryphon TherapeuticsGryphon Therapeutics is a biopharmaceutical company focused on the development of performance-enhanced protein therapeutics.-$26M
Healthtech
5 startups · $682M raised
VeraDermicsVeraDermics is a dermatology company that creates novel drug delivery mechanisms for a pain-free cure for skin conditions such as warts.United States$534MPoplar TherapeuticsPoplar Therapeutics anti-IgE therapy treats atopic diseases such as food allergy, allergic asthma, and atopic dermatitis.United States$50M
- R2River 2 RenalRiver 2 Renal is a developer of novel therapies intended to cure orphan diseases.-$40M
- PBPOINT BiomedicalPOINT Biomedical, develops technologies for imaging and drug deliveries.United States$29M
- RVRiver Vision DevelopmentRiver Vision Development develops a protein therapy for the treatment of Graves’ orbitopathy.United States$28M
How this map is made. Every startup here has raised money in a round we track that names SR One as an investor, the first in 2002. Each sits under its main sector, read from its rounds, and each sector shows its best-funded first; sectors with fewer than three companies are left off. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosCorporate investor · United StatesGoogle Ventures350 startups · 12 sectors · $99BCorporate investor · United StatesCoinbase Ventures305 startups · 12 sectors · $16BCorporate investor · United StatesIntel Capital295 startups · 12 sectors · $23BCorporate investor · United StatesSalesforce Ventures290 startups · 12 sectors · $200BCorporate investor · United StatesEndeavor Catalyst181 startups · 12 sectors · $22BCorporate investor · United StatesSamsung Next170 startups · 12 sectors · $15B
Raising from investors like SR One?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.